IRulya Therapeutics
IRLA32.0303.61% ( -1.200 )
IRulya Therapeutics (IRLA)
IRulya Therapeutics Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare di...
- Open
- 31.180
- High
- 34.930
- Low
- 31.180
- Prev. Close
- 33.230
- Volume
- 11.61K
- Turnover
- 382.26K
- Avg Price
- 32.937
- Bid/Ask Ratio
- --
- Amplitude
- 11.28%
- 52wk High
- 909.980
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.71%
- 52wk Low
- 15.100
- Float Mkt Cap
- 21.77M
- Market CapUSD
- 32.58M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -90.92
- EPSDynamic
- -77.82
- EPSStatic
- --
- BVPS
- -34.73
- P/B
- --
- Circulating Supply
- 679.68K
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 1.02M
- Min lot size
- 1
- Currency
- USD
IRulya Therapeutics Analyst Rating
View moreForecast & Rating
Oct 9, 2026Price forecast
$75.00134.16%
Forecast & RatingStrong buy
9analysts
- Strong buy66.67%
- Buy22.22%
- Hold11.11%
- Sell0.00%
- Strong sell0.00%
